Skip to content

Osborn Williams & Donohoe LLC: NVDA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Osborn Williams & Donohoe LLC on NVDA, newest first. How the timeline and the estimate are built.

Osborn Williams & Donohoe LLC held 5,225 NVDA shares at 2020-03-31 per its 13F-HR/A filed 2020-05-06.

the latest 13F is the newest step

  1. period ended2020-03-31
    13F/A 5,225 shares
    Change vs previous 13F -15 shares

    0.18% of the 13F portfolio, value $1,377,000.

    13F-HR/A 0001583000-20-000003 filed by Osborn Williams & Donohoe LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2019-12-31
    13F 5,240 shares
    Change vs previous 13F -195 shares

    0.12% of the 13F portfolio, value $1,233,000.

    13F-HR 0001583000-20-000001 filed by Osborn Williams & Donohoe LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2019-09-30
    13F 5,435 shares
    Change vs previous 13F +2,990 shares

    0.1% of the 13F portfolio, value $946,000.

    13F-HR 0001583000-19-000004 filed by Osborn Williams & Donohoe LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2019-06-30
    13F 2,445 shares
    Change vs previous 13F +25 shares

    0.04% of the 13F portfolio, value $402,000.

    13F-HR 0001583000-19-000003 filed by Osborn Williams & Donohoe LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2019-03-31
    13F 2,420 shares
    Change vs previous 13F not available

    0.05% of the 13F portfolio, value $464,000.

    13F-HR 0001583000-19-000002 filed by Osborn Williams & Donohoe LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).